“제주건마🚉 ┏OPDAL050.COM┓오피달리기 🏌제주출장안마💋제주OP🎓제주립카페💍제주오피🔑제주OP📞제주오피🤐”的搜索结果，显示 111-120 项，共有 13289 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating patients with previously untreated ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

9. 头颈癌 - 医生与科室 - 妙佑医疗国际

   了解喉癌、口腔癌、舌癌、扁桃体癌和其他累及头颈部的癌症的创新治疗方法。

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...